USC scientists discover a hidden Alzheimer’s trigger and a possible way to shut it down
Researchers have discovered promising compounds that may block a key source of brain inflammation tied to Alzheimer’s disease.
Date: May 26, 2026 Source: Keck School of Medicine of USC Summary: USC researchers have identified potential new drug compounds that may reduce the brain inflammation linked to Alzheimer’s disease, especially in people with the high-risk APOE4 gene. The compounds target cPLA2, an enzyme that seems to fuel harmful inflammation while also being important for normal brain activity. Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY
Researchers at the University of Southern California have identified experimental compounds that could help reduce the brain inflammation associated with Alzheimer's disease. The findings, published in the Nature journal npj Drug Discovery, focus on an enzyme called calcium-dependent phospholipase A2, or cPLA2, which appears to play an important role in inflammation inside the brain.
The USC team linked elevated cPLA2 activity to Alzheimer's risk while studying people who carry the APOE4 gene, the strongest known genetic risk factor for the disease. Although many APOE4 carriers never develop Alzheimer's, researchers found that those with higher cPLA2 activity were more likely to experience the disease.
Because cPLA2 also supports healthy brain function, scientists needed to find a way to reduce its harmful activity without completely shutting the enzyme down. Another challenge involved identifying compounds small enough to cross the blood-brain barrier so they could reach the brain effectively.
"In this study, we identified compounds that act selectively on cPLA2, with minimal effects on related PLA2 enzymes that are important for normal cellular function," said senior author Hussein Yassine, director of the Center for Personalized Brain Health at the Keck School of Medicine of USC. "Across cell-based and animal models, cPLA2 activity was reduced at low concentrations, indicating that the compounds are potent in brain-relevant systems."
Screening Billions of Molecules for Alzheimer's Drug Candidates
To search for potential treatments, researchers used large-scale computational screening methods to evaluate billions of possible molecules. The team prioritized compounds predicted to selectively target cPLA2, enter the brain, and remain active under biologically relevant conditions. The screening methods were developed by Vsevolod "Seva" Katritch of the USC Dornsife College of Letters, Arts and Sciences and the USC Michelson Center for Convergent Bioscience.
After narrowing down the list of candidates, pharmacologist Stan Louie of the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences led efforts to prepare the compounds for testing in animal models and measure how effectively they reached the brain.
One cPLA2 inhibitor emerged as the leading candidate after reducing harmful cPLA2 activation in human brain cells exposed to Alzheimer's-related stress conditions.
Promising Results in Early Brain and Animal Studies
In mouse studies, the compound successfully crossed the blood-brain barrier and influenced neuroinflammatory pathways linked to Alzheimer's disease. The results suggest that selectively inhibiting cPLA2 may represent a promising strategy for treating neurodegenerative disorders.
"Our goal is to find out whether targeting inflammation can alter Alzheimer's risk -- particularly in APOE4 carriers," Yassine said. "This next phase focuses not on promises, but on carefully determining whether modulating this pathway is safe, feasible, and ultimately meaningful for human disease."
In addition to Yassine, Louie, and Katritch, the study was led by co-first authors Anastasiia V. Sadybekov, Marlon Vincent Duro, and Shaowei Wang, all of USC. Other contributors included Brandon Ebright, Dante Dikeman, Cristelle Hugo, Bilal Ersen Kerman, Qiu-Lan Ma, Antonina L. Nazarova, Arman A. Sadybekov, and Isaac Asante.
The research received funding from the National Institute on Aging (U01AG094622, RF1AG076124, R01AG055770, R01AG067063, R01AG054434, R21AG056518, and P30AG066530); the National Institute of General Medical Sciences (R01GM147537); Department of Defense (W81XWH2110740), the Alzheimer's Drug Discovery Foundation (GC-201711-2014197); USC CTSI KL2 (UL1 TR000004); and donations from the Vranos and Tiny Foundations and Lynne Nauss.
Disclosure: Yassine, Katritch, and Louie are founders of PeBRx, a company developing cPLA2 inhibitors. No other authors reported competing interests.
Story Source:
Materials provided by Keck School of Medicine of USC. Note: Content may be edited for style and length.
Journal Reference:
- Anastasiia V. Sadybekov, Marlon Vincent Duro, Shaowei Wang, Brandon Ebright, Dante Dikeman, Cristelle Hugo, Bilal Ersen Kerman, Qiu-Lan Ma, Antonina L. Nazarova, Arman A. Sadybekov, Isaac Asante, Stan G. Louie, Vsevolod Katritch, Hussein N. Yassine. Development of potent, selective cPLA2 inhibitors for targeting neuroinflammation in Alzheimer’s disease and other neurodegenerative disorders. npj Drug Discovery, 2026; 3 (1) DOI: 10.1038/s44386-025-00035-0
Cite This Page:
Keck School of Medicine of USC. "USC scientists discover a hidden Alzheimer’s trigger and a possible way to shut it down." ScienceDaily. ScienceDaily, 26 May 2026. <www.sciencedaily.com/releases/2026/05/260525000504.htm>. Keck School of Medicine of USC. (2026, May 26). USC scientists discover a hidden Alzheimer’s trigger and a possible way to shut it down. ScienceDaily. Retrieved May 26, 2026 from www.sciencedaily.com/releases/2026/05/260525000504.htm Keck School of Medicine of USC. "USC scientists discover a hidden Alzheimer’s trigger and a possible way to shut it down." ScienceDaily. www.sciencedaily.com/releases/2026/05/260525000504.htm (accessed May 26, 2026).Explore More
from ScienceDaily RELATED STORIES Common Pneumonia Bacterium May Fuel Alzheimer’s Disease Feb. 21, 2026 A common bacterium best known for causing pneumonia and sinus infections may also play a surprising role in Alzheimer’s disease. Researchers found that Chlamydia pneumoniae can invade the retina ... This Simple Diet Could Help Protect Memory, Even With Alzheimer’s Genes Aug. 28, 2025 A Mediterranean-style diet was linked to lower dementia risk, especially in people with high-risk Alzheimer’s genes. The strongest benefits were seen in those with two APOE4 copies, showing diet ... Alzheimer's Risk Gene Undermines Insulation of Brain's 'Wiring' Nov. 16, 2022 In people carrying the APOE4 risk variant, a key brain cell type mismanages cholesterol needed to insulate neurons properly --another sign that APOE4 contributes to disease by disrupting lipids in ... How Microglia Contribute to Alzheimer's Disease Aug. 4, 2022 A new study shows how a type of cells called microglia contribute to the slowdown of neuron activity seen in Alzheimer's disease. The study found that microglia that express the APOE4 gene, one ... Researchers Untangle the APOE4 Gene, the Most Significant Genetic Risk Factor for Alzheimer's Disease June 23, 2022 Researchers have discovered two important novel aspects of the gene: 1) human genetic background inherited with APOE4 is unique to APOE4 patients and 2) the mechanistic defects due to APOE4 are ... Potential New Treatment Target for Alzheimer's Disease June 14, 2021 A new study not only sheds light on how the APOE4 gene may cause some of the pathologies associated with Alzheimer's disease, but also suggests a new treatment target that might help people who ... TRENDING AT SCITECHDAILY.comScientists Just Found Evidence That Asteroids May Have Helped Create Life on Earth
Scientists Create “Trojan Horse” Weight Loss Drug That Supercharges Results
Scientists Discover Major Errors in Al Gore-Founded Climate Pollution Database
Scientists Discover Grapes Can “Reprogram” Your Skin Against Sun Damage
Схожі новини
До відома: про брифінг у пресцентрі агентства "Інтерфакс-Україна" на тему "Реорганізація чи ліквідація: що насправді відбувається навколо Центру дитячої кардіології та кардіохірургії МОЗ України"
Serious staff shortages in Greek island hospitals and health centres, POEDIN finds
Мер міста на Одещині вимагав 35 тисяч доларів хабаря за будівництво електростанції
